Applications published 12 December 2007
Antibacterial 3",5-disubstituted 2,4"-dihydroxybiphenyl compounds, derivative and related methods
Colgate-Palmolive 1863432*
Compsns and methods for increasing metabolism, thermogenesis and/or muscular definition
Ripped Formulations 1863433*
A stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
Taro Pharmaceuticals; Rao, Srinivasa; Dixit, Suresh; Obe, Folusho; Goyal, Sandhya; Yacobi, Avraham 1863434*
Enhanced delivery of skin benefit agents
Unilever 1863435*
Chewing gum compsns of varenicline
Pfizer Products 1863442*
Rapidly disintegrating dosage form comprising magnesium carbonate heavy
Actavis 1863443*
Tablet containing steroid hormones
LTS Lohmann Therapie-Systeme; Bayer Schering Pharma 1863444*
• Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Watson Pharmaceuticals; Takeda Pharmaceutical Company 1863445*
• Controlled release pharmaceutical compsns of liothyronine and methods of making and using the same
King Pharmaceuticals Research & Development 1863446*
• Nonsteroidal immunomodulating kit and compsn and uses thereof
Foamix 1863447*
• Novel liposome compsns
Mebiopharm 1863448*
• Controlled absorption of statins in the intestine
Dexcel Pharma Technologies 1863449*
• Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
Elan Pharma International 1863450*
• Spherically shaped substances
Rafael-Armament Development Authority 1863451*
• Benzamustine pharmaceutical compsns for lyophilisation
Cephalon 1863452*
• Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release
Evonik Roehm 1863453*
• New pharmaceutical compsns useful in the treatment of migraine
Orexo 1863454*
• New pharmaceutical compsns useful in the treatment of Parkinson's disease
Orexo 1863455*
• New pharmaceutical compsns useful in the treatment of pain
Orexo 1863456*
• Pharmaceutical compsns of amlodipine and benazepril
Lupin 1863457*
• Solvent system for enhancing the solubility of pharmaceutical agents
Banner Pharmacaps 1863458*
• Flavoured vegetarian cellulose capsule and methods for producing said capsule
Capsuline 1863459*
• Solubilised ibuprofen
Losan Pharma 1863460*
• Sirtun related therapeutics and diagnostics for neurodegenerative diseases
The President and Fellows of Harvard College; Biomol International 1863461*
• Treatment of eye disorders with sirtuin modulators
Sirtris Pharmaceuticals 1863462*
• Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substituted by amino and phenyl groups
University of Virginia Patent Foundation 1863463*
• O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
Wyeth 1863464*
• Compsns for oral transmucosal delivery of metformin
Generex Pharmaceuticals 1863465*
• Synergistic salivation components
Takasago International 1863466*
• Combination of organic compounds
Novartis 1863467*
• A topical anaesthetic compsn
Animal Ethics 1863468*
• A topical analgesic compsn
Animal Ethics 1863469*
• A method for preventing and/or treating vaginal and vulval infections
Kimberley-Clark Worldwide 1863470*
• Use of angelic acid esters as an antiphlogistic active ingredient and antiphlogistic preparations
Miltitz Aromatics 1863471*
• Amino acid compsn for improving glucose tolerance
Abbott Laboratories 1863472*
• Novel use of lignan compounds
Amicogen 1863473*
• Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
Actelion Pharmaceuticals 1863474*
• Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
Actelion Pharmaceuticals 1863475*
• The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
Meda Pharma 1863476*
• 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
Novartis 1863477*
• Indoloquinone tumour radiation sensitisation
Spectrum Pharmaceuticals 1863478*
• Tetrahydrothiopyrano pyrazole cannabinoid modulators cross reference to related applications
Janssen Pharmaceutica 1863479*
• Compounds having immunomodulatory activity
Ganial Immunotherapeutics 1863480*
• Methods for administering ixabepilone
Bristol-Myers Squibb 1863481*
• Use of a substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines for the treatment of reperfusion injury and reperfusion damage
Bayer Healthcare 1863482*
• Bicyclic pyrazole compounds as antibacterial agents
Janssen Pharmaceutica 1863483*
• Substituted triazole derivatives as oxytocin antagonists
Pfizer 1863484*
• Alpha-7 neuronal nicotinic receptor ligand and antipsychotic compsns
Abbott Laboratories 1863485*
• Treatment of epilepsy with non-imidazole alkylamines histamine H3-receptor ligands
Bioproject 1863486*
• Treatment of Parkinson's disease, obstructive sleep apnoea. dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3-receptor ligands
Bioproject 1863487*
• Use of amino-substituted 8-N-benzimidazoles
Sanofi-Aventis 1863488*
• Pharmaceutical compsns containing a combination of cannabinoid receptor antagonist compound and antipsychotic agent
Sanofi-Aventis 1863489*
• Muscarinic modulators
Vertex Pharmaceuticals 1863490*
• Pharmaceutical combination of BCR-ABL and RAF inhibitors
Novartis; Novartis-Pharma 1863491*
• Use of megestrol acetate for improving heart function and the treatment of heart insufficiency
Par Pharmaceuticals 1863492*
• Corticosteroid containing formulation for treating psoriasis, eczema, ulcer and burns
El Masri, Mohamed Zakaria Ahmed 1863493*
• Use of vitamin D compounds to treat endometriosis
Bioxell 1863494*
• Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate and an allosteric effector of haemoglobin
Oxyplus 1863495*
• Method for the protection of trees
The Texas A&M University System; A&M University System; Syngenta Participations 1863496*
• Methods, compsns, and formulations for preventing or reducing adverse effects in a patient
Pericor Therapeutics 1863497*
• Compsn comprising isoorientin for suppressing histamine
Unigen 1863498*
• Method for inhibiting and/or treating vaginal infection
Kimberley-Clark Worldwide 1863499*
• Hepatitis C therapies
Biocryst Pharmaceuticals 1863500*
• Method of treating second and third degree burns using oxidative reductive potential water solution
Oculus Innovative Sciences 1863501*
• Method of treating skin ulcers using oxidative reductive potential water solution
Oculus Inventive Sciences; Alimi, Hojbar 1863502*
• Compsn and methods for delivering carbon monoxide (CO) and nitric acid (NO) CO to tissue using heme proteins as carriers
Sangart 1863503*
• Control of sucking lice
Microbial Products 1863504*
• Use of a non-photosynthetic, non-fructifying filamentous bacteria extract as a gamma-delta T lymphocyte activation and/or protection agent
L'Oreal 1863505*
• Nutritional products for ameliorating symptoms of rheumatoid arthritis
Abbott Laboratories 1863506*
• Compsns and methods for treating acne
Revance Therapeutics 1863507*
• Morinda citrifolia based antifungal formulations and methods
Tahitiamn Noni International; Isami, Fumiyuki; Wadsworth, John; Gerson, Scott; Palu, Afa Kehaati; Zhou, Bing-Nan 1863508*
• Ophthalmic compsn
Dr Gerhard Mann Chem. -pharma 1863509*
• Methods for treating Parkinson's disease
Voyager Pharmaceutical 1863510*
• Alkyl-glycoside enhanced vaccination
UAB Research Foundation 1863511*
• Enhancing MYC-dependent sensitivity of cancer to DR5 agonists
IRM 1863512*
• Potent and specific immunoproteasome inhibitors
The University of North Carolina at Chapel Hill; Mount Sinai School of Medicine 1863513*
• Therapeutic use of SCIN, a staphylococcal complement inhibitor in inflammatory diseases
UMC Utrecht Holding 1863514*
• Compsn containing beta-defensin 2
Henkel Kommanditgesellschaft auf Aktien 1863515*
• Compsns and methods involving MDA-7 for the treatment of cancer
Board of Regents, the University of Texas System 1863516*
